Trimester-by-trimester micronutrient shifts reshape pregnancy interpretation
Healthy pregnancy does not preserve a stable biochemical baseline. In a prospective cohort from Lianyungang, Jiangsu, repeated measurements across gestation showed that several trace elements and vitamins moved in predictable but nonuniform patterns, with some peaking in midpregnancy and others falling to their lowest point during the second trimester. The pattern matters because a single reference interval can blur physiologic change into apparent deficiency or, conversely, hide a real nutritional shortfall.
This longitudinal study followed women from early pregnancy through delivery and into the neonatal period, then restricted the final analysis to 43 participants with completed assessments and uncomplicated pregnancies. Whole-blood trace elements and serum vitamins were measured in the first, second, and third trimesters using high-precision analytic platforms, including ICP-MS and UHPLC-MS/MS. The design is important: unlike cross-sectional work, repeated sampling captures the moving target created by plasma volume expansion, altered maternal-fetal transfer, and changing metabolic demand.
Copper, calcium, and vitamin D reached their highest levels in the second trimester. Iron, zinc, magnesium, and lead fell to their lowest point in the same window. The second trimester therefore emerged as a biochemical hinge point, when nutrient distribution and maternal physiology appear to shift in opposite directions depending on the analyte. A separate group of measures did not follow a midpregnancy nadir at all: manganese, vitamin E, and vitamin K increased steadily across gestation, while several B vitamins trended downward overall and vitamin B12 remained relatively stable.
Midpregnancy appears to be the most volatile window
The second trimester is often treated as a period of relative clinical stability, yet the nutrient profile in this cohort suggests otherwise. Iron and zinc are classic examples of nutrients tightly linked to fetal growth, maternal erythropoiesis, and placental transport, so their midpregnancy decline is biologically plausible. Expanded maternal blood volume can dilute circulating concentrations, while fetal accretion increases demand for elements essential to enzymatic activity, immune function, and tissue growth.
Calcium and vitamin D moving in the opposite direction is equally instructive. Pregnancy alters mineral homeostasis through placental endocrine signaling and maternal adaptation to fetal skeletal development, and the observed second-trimester peak fits the idea that maternal handling of calcium-related metabolism is actively regulated rather than passively depleted. Copper also peaked in the second trimester, consistent with gestational changes in binding proteins and hepatic metabolism that can elevate circulating levels without implying pathologic excess.
Lead deserves separate attention even though the cohort focused on healthy pregnancies. Its decline in the second trimester does not remove concern; instead, it reminds clinicians that toxic metal exposure can vary over time and may be obscured if only one blood draw is obtained. Serial assessment provides a more faithful estimate of maternal burden than a single measurement anchored to a nonpregnant reference interval.
B vitamins moved downward while vitamin B12 stayed stable
The vitamin profile was not uniform. Several B vitamins showed an overall downward trajectory across pregnancy, a finding that fits with increased fetal transfer, higher maternal metabolic turnover, and the larger role these vitamins play in one-carbon metabolism and cellular replication. In practice, that biochemical pattern is relevant to fetal neural development, red cell production, and maternal energy metabolism, even when overt deficiency is not yet clinically obvious.
Vitamin B12 behaved differently. Its relative stability across the three trimesters suggests either tighter physiologic regulation or slower depletion compared with other water-soluble vitamins in this cohort. In clinical terms, stable B12 does not eliminate the need for surveillance, but it does argue against assuming that all water-soluble vitamins drift in parallel during gestation.
Fat-soluble vitamins also diverged. Vitamin E and vitamin K rose progressively throughout pregnancy, and vitamin D peaked in the second trimester. These trajectories likely reflect a combination of supplementation patterns, altered transport proteins, fetal requirements, and changes in lipid metabolism. The study did not systematically capture self-initiated vitamin D or other supplement use beyond routine folic acid and calcium, so supplement exposure may have contributed to some of the observed vitamin patterns. Even so, the trimester-specific direction of change remains clinically useful because it reflects the actual biochemical state encountered in routine prenatal care.
Why region-specific reference intervals now matter
The central message of this cohort is not that every pregnant patient needs broad nutritional testing. It is that interpretation must match gestational physiology and local population patterns. Micronutrient concentrations are shaped by diet, environment, ethnicity, and socioeconomic context, so reference values imported from nonpregnant adults or distant populations can misclassify healthy pregnancy as abnormal.
This study adds a practical layer to that argument by showing that the same analyte can move in different directions across the trimesters. A woman with lower iron in midpregnancy may be following a normal gestational pattern, while a persistently low concentration outside that physiologic window may carry a different meaning. The same logic applies to calcium, vitamin D, and the B vitamins. Without trimester-specific reference intervals and deficiency cutoffs, clinicians are left to infer risk from a moving biochemical target.
The cohort was small, and all final participants had favorable maternal and neonatal outcomes, so these data cannot define adverse thresholds or predict complications. Still, the measurements establish a useful longitudinal framework for healthy pregnancy in eastern China. They also create a foundation for future reference standards that are tied to gestational age rather than borrowed from nonpregnant populations. The next step is larger, regionally diverse sampling with enough power to define clinically meaningful lower and upper limits for each trimester, alongside outcome-linked deficiency thresholds.